Chosen Diagnostics
Chosen Diagnostics
Chosen Diagnostics is a personalized medicine diagnostics provider developing a novel platform capable of predicting drug resistance and regiments for targeted treatments, especially in the oncology field. The Chosen diagnostics platform is a leap forward from current pharmacogenomic personalized medicine approaches by its capability of incorporating both direct measurements of target protein structures as well as genetic biomarkers to predict an individual patient’s therapeutic response to a drug. The Chosen Diagnostics technology will be marketed as a clinical diagnostic essay to simply and rapidly assess whether an individual patient is likely to respond to a specific drug or drug candidates. The technology is also capable of selecting among different medications, and even tailors dosages most likely to result in optimal treatment benefit for that particular patient.